scispace - formally typeset
Open AccessJournal ArticleDOI

WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.

Reads0
Chats0
TLDR
It is suggested that high-phosphate may activate WNT/β-catenin signaling through different pathways, and the activated WNT-3A/ β-catanin signaling, through direct downstream target Runx2, could play an important role in promoting VOT and AMC.
About
This article is published in Experimental Cell Research.The article was published on 2016-07-15 and is currently open access. It has received 159 citations till now. The article focuses on the topics: Wnt signaling pathway & DKK1.

read more

Citations
More filters
Journal ArticleDOI

WNT Signaling in Cardiac and Vascular Disease

TL;DR: A general picture is emerging that excessive stimulation of WNT signaling adversely affects cardiovascular pathology, and a rapidly increasing collection of drugs interfering at different levels of W NT signaling will allow the evaluation of therapeutic interventions in the pathway in relevant animal models of cardiovascular diseases and eventually in patients in the near future.
Journal ArticleDOI

WNT–β-catenin signalling — a versatile player in kidney injury and repair

TL;DR: Advances in the understanding of WNT–β-catenin signalling and its regulation during kidney injury, along with its potential diagnostic and therapeutic implications are discussed.
Journal ArticleDOI

The art of building bone: emerging role of chondrocyte-to-osteoblast transdifferentiation in endochondral ossification.

TL;DR: A better understanding of this process could lead to new therapies to boost fracture healing and tackle bone-wasting disorders, as well as the possible signaling pathways that contribute to chondrocyte-to-osteoblast transdifferentiation processes.
Journal ArticleDOI

Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.

TL;DR: Critical intracellular pathways controlling osteo-/chondrogenic transdifferentiation of VSMCs are addressed and elucidating these pathways holds a significant promise to open novel therapeutic opportunities counteracting the progression of vascular calcification in CKD.
Journal ArticleDOI

Role of phosphate sensing in bone and mineral metabolism

TL;DR: The metabolic effects of Pi are discussed, which are mediated by Pi transporters, inositol pyrophosphates and SYG1–Pho81–XPR1 (SPX)-domain proteins to maintain cellular phosphate homeostasis in the musculoskeletal system.
References
More filters
Journal ArticleDOI

The many faces and functions of β‐catenin

TL;DR: One focus will be the interaction of β‐catenin with different transcription factors and the potential implications of these interactions for direct cross‐talk between β‐ catenin and non‐Wnt signalling pathways.
Journal ArticleDOI

Canonical Wnt/β-Catenin Signaling Prevents Osteoblasts from Differentiating into Chondrocytes

TL;DR: It is shown by conditionally deleting beta-catenin in limb and head mesenchyme that beta- catenin is required for osteoblast lineage differentiation, preventing transdifferentiation of osteoblastic cells into chondrocytes.
Journal ArticleDOI

Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression

TL;DR: It is proposed that WNT/TCF1 signaling, like bone morphogenetic protein/transforming growth factor-β signaling, activates Runx2 gene expression in mesenchymal cells for the control of osteoblast differentiation and skeletal development.
Journal ArticleDOI

Proximal events in Wnt signal transduction

TL;DR: Intriguingly, the transmembrane receptor Tyr kinases Ror2 and Ryk, as well as Frizzled receptors that act independently of LRP5 or LRP6, function as receptors for Wnt and activate β-catenin-independent pathways, which leads to changes in cell movement and polarity and to the antagonism of the β- catenin pathway.
Journal ArticleDOI

Vascular Calcification Pathobiology of a Multifaceted Disease

TL;DR: Clinically, vascular calcification is now accepted as a valuable predictor of coronary heart disease, and, conversely, many treatments for cardiovascular disease such as statins, antioxidants, hormone replacement therapy, ACE inhibitors, fish oils, and calcium channel blockers may affect bone health.
Related Papers (5)